Paricalcitol
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical)
Reference34 articles.
1. Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings
2. Strategies to minimize bone disease in renal failure
3. Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis
4. Association of Elevated Serum PO4, Ca × PO4Product, and Parathyroid Hormone with Cardiac Mortality Risk in Chronic Hemodialysis Patients
5. Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The effect of oral supplementation of Paricalcitol on C-reactive protein levels in chronic kidney disease patients: GRADE-assessed systematic review and dose-response meta-analysis of data from randomized controlled trials;BMC Pharmacology and Toxicology;2024-02-23
2. Paricalcitol Improved Cardiac Hypertrophy and Fibrosis through Upregulation of Fibroblast Growth Factor-23 and Downregulation of Transforming Growth Factor-beta in a Rat Model of Isoproterenol-Induced Cardiomyopathy;Chinese Journal of Physiology;2023
3. Progress in the Treatment of Secondary Hy-perparathyroidism;Advances in Clinical Medicine;2023
4. Systematic Review of the Treatment of Persistent Hyperparathyroidism Following Kidney Transplantation;Biomedicines;2022-12-22
5. Effectiveness and Safety of Ultrasound-Guided Local Paricalcitol Injection in Treating Secondary Hyperparathyroidism in ESRD: A Retrospective Study;Journal of Clinical Medicine;2022-11-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3